﻿<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <atom:link href="http://www.genengnews.com/media/files/rss/TRANSLATIONAL-MEDICINE-autoimmune-diseases.xml" rel="self" type="application/rss+xml" />
    <title>Genetic Engineering &amp; Biotechnology News - Autoimmune Diseases</title>
    <description>The most recent news on developments in the field of autoimmune diseases.</description>
    <lastBuildDate>Tue, 11 Jun 2013 10:45:27 -0400</lastBuildDate>
    <link>http://www.genengnews.com/media/files/rss/TRANSLATIONAL-MEDICINE-autoimmune-diseases.xml</link>
    <item>
      <title>Questcor Acquires Synacthen Rights from Novartis in Up To $135M+ Deal</title>
      <link>http://www.genengnews.com/gen-news-highlights/questcor-acquires-synacthen-rights-from-novartis-in-up-to-135m-deal/81248466/</link>
      <description></description>
      <guid>http://www.genengnews.com/gen-news-highlights/questcor-acquires-synacthen-rights-from-novartis-in-up-to-135m-deal/81248466/</guid>
      <pubDate>Tue, 11 Jun 2013 09:52:00 -0400</pubDate>
      <media:thumbnail url="http://www.genengnews.com/media/images/newsletters/genlogo_red.gif" />
    </item>
  </channel>
</rss>